Registry for Exablate treatment in Parkinson’s with medication problems
Part of Brain & nervous system clinical trials.
This trial is a real-world registry that follows people with Parkinson’s who are planning to get an Exablate 4000 procedure (a focused ultrasound treatment) for one-sided symptoms that are difficult to control with medication. It mainly checks outcomes and safety over time, helping doctors understand how well this treatment works in everyday care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 30 years old or older
- Be planning to have an Exablate procedure for Parkinson’s motor complications (medication problems) using your usual care plan
- Have the procedure for a one-sided (unilateral) treatment plan as planned by your local doctor
- Be willing to follow the study’s schedule, including required visits and instructions
- Sign the informed consent form (and receive a copy for your records)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a record of people who receive the Vercise deep brain stimulation system. It helps doctors learn how the treatment is used in real-world care and how patients do over time.
This study looks at how deep brain stimulation (an implanted brain device) affects Parkinson’s symptoms, especially movement problems like freezing, slowness, or involuntary movements. It may help people whose symptoms are not fully controlled by standard Parkinson medicines.
This study follows people with Parkinson’s who have troublesome “ups and downs” or involuntary movements, and who need a device/infusion treatment like deep brain stimulation, an apomorphine pump, or a Duodopa pump. It helps doctors see how these second-line treatments are working in real life and what outcomes they produce.
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
This study follows people who are getting an Exablate procedure to treat medication-resistant, tremor-dominant Parkinson’s. It aims to track safety and outcomes in real-world care after the treatment is approved.
This trial tests a non-surgical treatment that uses focused ultrasound waves to create tiny lesions in a specific part of the brain to improve Parkinson's symptoms like stiffness, slowness, and involuntary movements. It may be an option for people who have had Parkinson's for a while and have motor complications from their medications.
Hear when a new Movement Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.